Come up with a name for your new list and we'll add to it:
BioEclosion raised a round of funding on June 08, 2017. Investors include
IQS Next Tech.
BioEclosion develops and produces new clinical diagnostic devices based on state-of-the-art biosensors. The company's product "Celifast" helps enable the fast diagnosis of celiac disease at the point …